Controlled trial of antituberculous chemotherapy in Crohn's disease: A five year follow up study

Gut

Volumn 42, Issue 4, 1998, Pages 497-500

  Thomas, G A O ^a   Swift, G L ^c   Green, J T ^a   Newcombe, R G ^b   Braniff Mathews, C ^a   Rhodes, J ^a   Wilkinson, S ^d   Strohmeyer, G ^e   Kreuzpainter, G ^e  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c LLANDOUGH HOSPITAL   (United Kingdom)

^d DERRIFORD HOSPITAL   (United Kingdom)

^e HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Antituberculus chemotherapy; Crohn's disease; Mycobacteria

Indexed keywords

ETHAMBUTOL; ISONIAZID; PREDNISONE; RIFAMPICIN; SALICYLIC ACID DERIVATIVE; TUBERCULOSTATIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DRUG EFFICACY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031902581     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.42.4.497     Document Type: Article

References (16)

1. Stanford JL, White SA, Burnham WR, et al. Mycobacteria and inflammatory bowel disease. Lancet 1979;i:444.
2. Graham DY, Markesich DC, Yoshimura HH. Mycobacteria and inflammatory bowel disease; results of culture. Gastroenterology 1987;92:436-42.
3. Morgan KL. Johne's and Crohn's; chronic inflammatory bowel diseases of infectious aetiology? Lancet 1987;i:1017-19.
4. Shultz MG, Reider HL, Hersh T, et al. Remission of Crohn's disease with anti-mycobacterial chemotherapy. Lancet 1987;ii:1391-2.
5. Picciotto A, Gesu GP, Schito GC, et a/. Antimycobacterial chemotherapy in 2 cases of inflammatory bowel disease. Lancet 1988;ii:536-7.
6. Swift GL, Srivastava ED, Stone R, et al. Controlled trial of anti-tuberculous chemotherapy for two years in Crohn's disease. Gut 1994;35:363-8.
7. Best ER, Bektel JM, Singleton JW, et al. Development of a Crohn's Disease Activity Index: National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439-44.
8. Warren JB, Rees HC, Cox TM, Remission of Crohn's disease with tuberculosis chemotherapy. N Engl J Med 1986;314:182.
9. Elliot PR, Burnham WR, Berghouse LM, et al. Sulphadoxine-pyrimethamine therapy in Crohn's disease. Digestion 1982,23:132-4.
10. Rutgeerts P, Geboes K, Vantrappen G, et al. Rifabutin and ethambutol do not help recurrent Crohn's disease in the neoterminal ileum. J Clin Gastroenterol 1992;15:24-8.
11. Graham DY, Al-Assi MT, Robinson M. Prolonged remission in Crohn's disease following therapy for Mycobacterium paratuberculosis [abstract]. Gastroenterology 1995; 108:A826.
12. Hampson SJ, Parker MC, Saverymuttu SH, et al. Quadruple anti-mycobacterial chemotherapay in Crohn's disease; results at 9 months of a pilot study in 20 patients. Aliment Pharmacol Ther 1989;3:343-52.
13. Shaffer JL, Hughes S, Linaker BD, et al. Controlled trial of rifampicin and ethambutol in Crohn's disease. Gut 1984;25:203-5.
14. Basilisco G, Ranzi T, Campanini C, et al. Controlled trial of rifabutin in Crohn's disease Curr Threr Res 1989;46:242-50.
15. Afdhal NH, Long A, Lennon J, et al. Controlled trial of antimycobacterial therapy in Crohn's disease. Clofazimine versus placebo. Dig Dis Sci 1991;36:449-53.
16. Prantera C, Kohn A, Mangiarotti R, et al. Antimycobacterial therapy in Crohn's disease; results of a controlled, double-blind trial with a multiple antibiotic regimen. Am J Gastroenterol 1994;89:513-18.